AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2020
May 15, 2020
34705_dirs_2020-05-15_54250abc-8b73-4291-959a-4fae4f3d19a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2020-03-31
Reporting Person: GRIMALDI CLAUDIA (Vice President & PFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-22 | Common Stock | G | 15000 | — | Disposed | 837987 | Direct |
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15